Lobenzarit Disodium and Its Effects on Inflammation
Author Information
Author(s): J. Padrón, A. Rojas, L. Glaria, L. Caveda, R. Delgado, M. Torres, O. Martinez, E. López, A. Beltrán, M. Palacios
Primary Institution: Center of Pharmaceutical Chemistry, Department of Pharmacology and Toxicology, Havana City, Cuba
Hypothesis
Does lobenzarit disodium (CCA) inhibit the production of guanosine 3',5'-cyclic monophosphate (cGMP) and affect nitric oxide generation?
Conclusion
Lobenzarit disodium significantly inhibits cGMP production and interferes with nitric oxide generation.
Supporting Evidence
- CCA inhibits cGMP production almost completely at concentrations of 1 mM.
- CCA shows a concentration-dependent inhibition of nitric oxide generation.
- Previous findings suggest CCA enhances the T suppressor/T helper lymphocyte ratio.
Takeaway
Lobenzarit disodium is a new drug that helps reduce inflammation by blocking certain chemicals in the body.
Methodology
The study involved biochemical assays to measure cGMP and citrulline production in rat brain cytosol after treatment with CCA.
Participant Demographics
Male Sprague-Dawley rats weighing 180-200 g were used.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website